CliffBio
small molecule

PREZCOBIX

COBICISTAT; DARUNAVIR ETHANOLATE

Loss of exclusivityOctober 2032latest FDA-listed patent expiry
CompanyJANSSEN PRODUCTS LP

Drug detail

Brand namePREZCOBIX
Active ingredientCOBICISTAT; DARUNAVIR ETHANOLATE
Strength150MG;EQ 800MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2015
Marketing statusRX

Listed patents

PatentExpiresType
10039718October 2032product
8148374September 2029substance, product
7700645*PEDJune 2027—
7700645December 2026substance, product

More from JANSSEN PRODUCTS LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.